Article on Antibody Drug Discovery

Antibody drug discovery is a critical focus in modern biotechnology, offering targeted solutions for complex diseases. This category explores the latest methodologies, emerging technologies, and key challenges in developing effective antibody-based therapeutics.

Featured Article

Immunotherapy Target: CD19 Antigen

CD19 remains a hot target in immunotherapy, driving innovation across a range of diseases. This is evidenced by recent approvals for new treatments in multiple sclerosis and leukemia and a major acquisition in the bispecific antibody space:

Browse our products:

Targeted Therapies for Inflammatory Bowel Disease (IBD)

Targeted Therapies for Inflammatory Bowel Disease (IBD)

May 28, 2025

6 min read

The Landscape of GPCR-targeting Antibody Drug Development

The Landscape of GPCR-targeting Antibody Drug Development

May 9, 2025

9 min read

For Better Symptom Relief: Targeted Therapy for Asthma

For Better Symptom Relief: Targeted Therapy for Asthma

April 15, 2025

11 min read

At the Crossroads of Metabolic and Cancer Therapeutics — GDF15

At the Crossroads of Metabolic and Cancer Therapeutics — GDF15

April 1, 2025

7 min read

Immunotherapy Target: CD19 Antigen

Immunotherapy Target: CD19 Antigen

February 4, 2025

7 min read

MSLN Targeted Drugs Entering the Fast Lane

MSLN Targeted Drugs Entering the Fast Lane

February 29, 2024

5 min read

Focus on Hematoma Target Fms-like Tyrosine Kinase 3 (FLT3)

Focus on Hematoma Target Fms-like Tyrosine Kinase 3 (FLT3)

January 9, 2023

6 min read

DKK1: A Wnt Pathway Regulator

DKK1: A Wnt Pathway Regulator

January 6, 2023

5 min read

GDF15-GFRAL breaks into the new drug track

GDF15-GFRAL breaks into the new drug track

July 12, 2022

7 min read

Have questions? Get in touch!

support@kactusbio.us

Antibody Drug Discovery Insights & Trends

↑